Rachel Occhiogrosso Abelman

4PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 22, 2025
Current landscape of sequencing ADCs in metastatic breast cancer.

Shannon McLaughlin, Lis V Ravani, Beverly Moy

|Jan 02, 2025
TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.

Rachel O Abelman, Bogang Wu, Haley Barnes

|May 06, 2024
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer.

Aditya Bardia, Sheng Sun, Nayana Thimmiah

|Feb 25, 2023
Mechanisms of Resistance to Antibody-Drug Conjugates.

Rachel Occhiogrosso Abelman, Bogang Wu, Laura M Spring

Pageof 1